Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1835579 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $5.57Day −3.30%1Y −63.4%Off 52W high −69.0%Vol (1Y) 74.5%
Daily closing price, split-adjusted to the current basis; 1y shown of 243 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.8% of sh out |
| Days to cover59.1d |
| 13F net flow (QoQ)+1.22% |
| Top-10 13F concentration99.6% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$800,000 |
| Earnings (TTM)-$49.9M |
| Net margin−5668.6% |
| Debt / equity0.00× |
| Sales growth 3Y−62.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−19.3% |
| 1Y−63.4% |
| Since incept. (ann.)−65.9% |
Total return through 2026-07-29 · series begins 2025-07-28. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)74.5% |
| Ann. volatility (3Y)74.5% |
| Sharpe (1Y)−1.11 |
| Sharpe (3Y)−1.11 |
| Max drawdown (1Y)−74.6% |
| Max drawdown (3Y)−74.6% |
| Beta (3Y vs SPY)1.61 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Exor N.V. | 182.5M | $5.0B | — | +0.0% |
| ORBIMED ADVISORS LLC | 6.6M | $24M | — | +0.0% |
| BVF INC/IL | 1.1M | $6M | — | +38.4% |
| Blue Owl Capital Holdings LP | 959,337 | $5M | — | +16.5% |
| Cable Car Capital, LP | 754,749 | $4M | — | +17.2% |
| Omega Fund Management, LLC | 455,361 | $2M | — | +0.0% |
| RTW INVESTMENTS, LP | 334,445 | $2M | — | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 325,155 | $2M | — | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding suppressed: the summed institutional 13F holdings (194,110,962) exceed the latest reported shares-outstanding count (48,258,111) by more than securities-lending double counting can explain (FINRA short interest 470,339 shares at 2026-04-30), so the share count is stale or wrong (common for annual 20-F foreign private issuers after a share issuance) and a percentage would be fabricated. Holder share counts are shown as filed.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.95 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$2.91 | — | $0 | −100.0% |
| 2025-06-30 | 2025-07-24 | −$0.06 | — | — | — |
| 2025-03-31 | 2025-05-08 | −$3.80 | — | $800,000 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
